Proactive therapeutic infliximab monitoring during induction phase in inflammatory bowel disease

被引：0
|
作者：
Gonzalez Vivo, M. [1 ,2 ]
Carballo Martinez, N. [2 ,3 ]
Padulles Zamora, N. [4 ]
Colominas Gonzalez, E. [2 ,3 ]
Murciano Gonzalo, F. [1 ]
Abril Rodriguez, L. [1 ]
Marquez-Mosquera, L. [1 ,2 ]
机构：
[1] Hosp Mar, Dept Gastroenterol, Barcelona, Spain
[2] Hosp Mar, IMIM, Med Res Inst, Barcelona, Spain
[3] Hosp Mar, Pharm Dept, Barcelona, Spain
[4] Hosp Univ Bellvitge, Pharm Dept, Lhospitalet De Llobregat, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P713
引用
收藏
页码：842 / 843
页数：2
相关论文
共 50 条
  • [1] Usefulness of therapeutic drug monitoring of infliximab during the induction period in patients with inflammatory bowel disease
    Gil Candel, Mayte
    Gascon Canovas, Juan Jose
    Urbieta Sanz, Elena
    Gomez Espin, Rosa
    Nicolas de Prado, Isabel
    Iniesta Navalon, Carles
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2020, 112 (05) : 360 - 366
  • [2] A role for therapeutic drug-monitoring during infliximab induction treatment in inflammatory bowel disease?
    Rasmussen, M.
    Brynskov, J.
    Ainsworth, M. A.
    Buhl, S.
    Bendtzen, K.
    Steenholdt, C.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S378 - S378
  • [3] Therapeutic drug monitoring of infliximab induction therapy in inflammatory bowel disease.
    Sanchez-Hernandez, Jose German
    Fraile, Sofia
    Rebollo, Noemi
    Laso, Esther
    Pordomingo, Alejandra F.
    Calvo, M. V.
    PHARMACOTHERAPY, 2017, 37 (06): : E57 - E57
  • [4] Proactive therapeutic drug monitoring of infliximab leads to durability of treatment in children with Inflammatory Bowel Disease
    Chuah, C. W.
    Eldredge, J.
    Magoffin, A.
    O'Loughlin, E., V
    Park, C. J.
    Puppi, J.
    Siew, S.
    Stormon, M.
    Thacker, K.
    Dutt, S.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i2099 - i2099
  • [5] Proactive Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease Patients Receiving Infliximab and Biosimilars
    Aktay, Atiye
    Odolil, Abel
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (12S): : S21 - S21
  • [6] Proactive therapeutic drug monitoring (TDM) of infliximab leads to durability of treatment in children with inflammatory bowel disease
    Chuah, Cher Wei
    Dutt, Shoma
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 325 - 325
  • [7] COST EFFECTIVENESS OF A PROACTIVE THERAPEUTIC DRUG MONITORING STRATEGY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING INFLIXIMAB
    Doherty, Jayne
    Varley, Rachel
    Kennedy, Una
    Healy, Martin
    Dunne, Cara
    Maccarthy, Finbar
    Mckiernan, Susan
    Hartery, Karen
    Kevans, David
    GASTROENTEROLOGY, 2021, 160 (06) : S692 - S693
  • [8] Time of Therapeutic Drug Monitoring of infliximab during induction and its relationship with clinical remission in Inflammatory Bowel Disease
    Munoz-Villafranca, C.
    Arreba, P.
    Gomez, M.
    Ispizua Madariaga, N.
    Buendia, L.
    Lopez, M. L.
    Ugarte, A.
    de la Fuente, I.
    Prado, N.
    Irusta, L.
    Jimenez, M. A.
    Santa Cruz, M.
    Gonzalez, M.
    Bilbao, A.
    Ortiz de Zarate, J.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 723 - 723
  • [9] Cost Effectiveness of a Proactive Therapeutic Drug Monitoring Strategy in Patients with Inflammatory Bowel Disease Receiving Infliximab
    Doherty, J.
    Varley, R.
    Healy, M.
    Dunne, C.
    Mac Carthy, E.
    Mc Kiernan, S.
    Hartery, K.
    Kevans, D.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S445 - S446
  • [10] Usefulness of therapeutic monitoring of infliximab in the treatment of inflammatory bowel disease
    Quera, Rodrigo
    Moreno, Mauricio
    Simian, Daniela
    Ibanez, Patricio
    Lubascher, Jaime
    Figueroa, Carolina
    Flores, Lilian
    Kronberg, Udo
    Pizarro, Gonzalo
    Fluxa, Daniela
    REVISTA MEDICA DE CHILE, 2018, 146 (11) : 1241 - 1251
12345